A Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of OsrhCT in Patients With Pleurisy
Clinical trial NCT06525272 · UNKNOWN
Trial details
- NCT number
- NCT06525272
- Sponsor
- Healthgen Biotechnology Corp.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-01
- Primary completion
- 2025-07-01
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.